Pharma companies raise prices on nearly 1,000 drugs as the Inflation Reduction Act phases in new federal restrictions in coming years. What to know.
Author: Ken Alltucker, USA TODAY
‘This is alarming’: Childhood vaccination rates drop as measles and polio outbreaks emerge
Rising rates of of nonvaccinated children raises the risk for diseases to reemerge as vaccination rates slip, experts sya.
Medicare launches plan to negotiate prices for the costliest drugs. Here’s what to know.
As part of the Inflation Reduction Act, Medicare will negotiate drug prices, limit annual price hikes and cap insulin costs paid by older Americans.
FDA approves new Alzheimer’s drug lecanemab that appears to slow the memory-robbing disease
Federal drug regulators on Friday approved lecanemab, sold under the brand name Leqembi, an Alzheimer’s drug that appears to slow the disease.
Half of ambulance rides yield surprise medical bills. What’s being done to protect people?
No Surprises Act protects consumers from costly surprise bills during emergency medical care, but not from ambulance bills.
‘Eat what you kill’: How a fentanyl drugmaker bribed doctors, harmed patients and collected millions
Documents reveal details about the culture of greed, power and sales at fentanyl drugmaker Insys, whose executives were jailed amid the opioid crisis.
Here’s why private Medicare plans are set to pass traditional Medicare enrollment
More than 28 million older adults enrolled in Medicare plans administered by private insurance companies rather than the federal government.
‘Calm before the storm’: Health insurance costs set to spike after they stayed mostly flat in 2022, survey finds
Kaiser Family Foundation survey reports average cost for an employer-provided health increased just 1% this year.
Biden administration vows tougher oversight of poor-performing nursing homes with safety issues
The Biden administration will bolster oversight of poor-performing nursing homes with escalating fines and terminating federal funding.
More than 1.3M Americans ration life-saving insulin due to cost. That’s ‘very worrisome’ to doctors.
Doctors warn the high cost of insulin puts all type 1 and some type 2 diabetes patients at risk of medical complications, hospitalization and death.